Related Experiment Video

Updated: Apr 4, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.6K

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and

Beverly A Teicher1, Eric Polley2, Mark Kunkel3

  • 1Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. teicherba@mail.nih.gov.

Molecular Cancer Therapeutics
|September 10, 2015
PubMed

Insights

This study screened 63 sarcoma cell lines against 445 oncology agents, identifying promising drug targets and responses. The findings offer a valuable resource for developing new sarcoma treatments.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Sarcoma treatment is challenging due to diverse phenotypes and genotypes.
  • A comprehensive screening approach is needed to identify effective therapeutic strategies.

Purpose of the Study:

  • To screen a large panel of human sarcoma cell lines against a broad library of oncology agents.
  • To investigate drug response, target specificity, and gene/microRNA expression patterns in sarcoma.

Main Methods:

  • Screened 63 adult and pediatric sarcoma cell lines with 100 FDA-approved and 345 investigational oncology agents.
  • Utilized Alamar blue assay over 96 hours across nine drug concentrations.
  • Analyzed gene expression via exon arrays and microRNA expression via digital detection assays.

Main Results:

  • Presented results for inhibitors targeting aurora kinase, IGF-1R, MEK, BET bromodomain, and PARP1.
  • Detailed chemical structures, IC50 heat maps, and concentration response curves for selected compounds.
  • Highlighted two cases of exceptional responders, including their molecular profiles.

Conclusions:

  • The study provides a rich dataset for understanding sarcoma heterogeneity and drug response.
  • The publicly available data serves as a crucial resource for the cancer research community.
  • Identified potential therapeutic targets and drug candidates for sarcoma treatment.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.9K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K